VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AVAHAveanna Healthcare Holdings Inc.
$8.66$1.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksAVAHCash Flow

Aveanna Healthcare Holdings Inc. (AVAH) Cash Flow Statement

8Y historyFree accessUpdated daily

Cash flow generation is inconsistent, evidenced by a $50.7 million working capital outflow in 2026Q1 that significantly offset reported net income.

AVAH Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMJan'26Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18
Cash from Operations138.84M122.24M32.64M22.67M-48.4M-11.35M116.62M-8.71M21.6M
Operating CF Margin %-5.02%1.61%1.2%-2.71%-0.68%7.8%-0.63%1.72%
Operating CF Growth %3184.9%274.54%43.95%146.84%-326.45%-109.73%1438.28%-140.35%-
Net Income261.49M225.03M-10.93M-134.52M-662.03M-117.04M-57.05M-76.52M-47.15M
Depreciation & Amortization705K28.22M31.16M30.1M38.82M35.39M30.22M27.01M11.94M
Stock-Based Compensation-11M017.46M13.16M15.89M14.43M3.27M1.95M2.12M
Deferred Taxes-612K-143.03M1.03M1.01M-115K1.31M-6.42M-919K-3.63M
Other Non-Cash Items-106.86M64.67M23.87M136.32M601.26M125.89M90.06M26.7M23.56M
Working Capital Changes-4.9M-52.66M-29.97M-23.4M-42.22M-71.33M56.54M13.06M34.76M
Change in Receivables10.31M-30.22M-28.64M-15.32M-3.23M-8.81M8.56M3.34M-7.96M
Change in Inventory00000-27.06M0-13.2M15.4M
Change in Payables8.52M-6.23M6.45M-13.92M-3.92M-11.7M-6.81M19.29M21.51M
Cash from Investing-24.51M-22.3M-6.32M-8.79M-25.29M-681.83M-193.54M-17.82M-229.55M
Capital Expenditures-2.21M-7.45M-6.32M-6.12M-12.01M-15.95M-15.24M-16.64M-19.58M
CapEx % of Revenue0.09%0.31%0.31%0.32%0.67%0.95%1.02%1.2%1.56%
Acquisitions0-14.85M00-1.55M-666.91M-178.31M-1.19M-209.97M
Investments---------
Other Investing-22.3M00-2.68M-11.27M0000
Cash from Financing3.45M9.03M14.03M10.85M62.42M586.33M210.94M21.86M204.15M
Debt Issued (Net)-655K-3.76M-2.36M-5.73M60.15M161.59M136.69M68.94M149.73M
Equity Issued (Net)-1.52M6.52M3.09M945K4.01M477.69M50M054.42M
Dividends Paid000000000
Share Repurchases000000000
Other Financing5.63M6.27M13.3M15.63M-1.74M-52.95M24.25M-47.07M0
Net Change in Cash117.78M108.97M40.35M24.73M-11.27M-106.86M134.02M-4.67M-3.8M
Free Cash Flow136.63M114.79M26.32M16.56M-60.41M-27.3M101.38M-25.35M2.02M
FCF Margin %5.42%4.72%1.3%0.87%-3.38%-1.63%6.78%-1.83%0.16%
FCF Growth %377.42%336.17%58.96%127.4%-121.3%-126.93%499.91%-1356.87%-
FCF per Share0.620.530.140.09-0.33-0.150.55-0.140.01
FCF Conversion (FCF/Net Income)0.52x0.54x-2.99x-0.17x0.07x0.10x-2.04x0.11x-0.46x
Interest Paid00152.51M137.85M102.53M58.96M73.05M92.81M62.77M
Taxes Paid005.71M1.14M1.59M5.28M2.17M1.55M3.15M

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrained
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Medicaid reimbursement cycle volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality Remains Highly Volatile

As reported in recent financial disclosures, the relationship between net income and operating cash flow is frequently disjointed, with the OCF/NI ratio swinging from a high of 2.36 in 2025Q3 to a negative 1.66 in 2025Q1, indicating significant accrual-based distortions in reported profitability.

The persistent gap between net income and cash generation suggests that reported earnings are heavily influenced by non-cash adjustments and timing differences in revenue recognition. Investors should interpret these fluctuations as a sign that accounting accruals, rather than core operational cash flow, are driving the bottom line in any given quarter.

Free Cash Flow Generation Inconsistent

Based on the company's quarterly cash flow statements, free cash flow trajectory remains erratic, alternating between positive margins and periods of cash burn, such as the negative 2.0% FCF margin observed in 2025Q1, which highlights the difficulty in sustaining consistent cash conversion.

The inability to maintain positive free cash flow across consecutive quarters suggests that the business model is highly sensitive to working capital swings and operational timing. This inconsistency complicates the assessment of the company's long-term ability to self-fund its growth initiatives without relying on external financing.

Working Capital Swings Obscure Liquidity

According to the provided cash flow data, working capital changes are a primary driver of quarterly cash volatility, evidenced by a massive $50.7 million outflow in 2026Q1, which significantly offset the company's reported net income and pressured overall liquidity during the period.

These large, periodic working capital outflows suggest challenges in managing the revenue cycle, likely stemming from the complexity of billing multiple state Medicaid programs. The reliance on government reimbursement creates a structural lag that appears to frequently trap cash in accounts receivable, limiting the company's operational flexibility.

Capital Intensity Remains Relatively Low

As indicated by the company's historical cash flow filings, capital expenditures remain modest, with CapEx/Revenue ratios consistently hovering below 1% over the last ten quarters, suggesting that the business is not overly burdened by heavy physical asset replacement or infrastructure maintenance requirements.

The low capital intensity reflects the service-oriented nature of the pediatric private duty nursing model, which prioritizes human capital over physical plant investment. While this preserves cash, it also implies that the company's competitive moat is not protected by significant capital barriers, but rather by regulatory and labor-related hurdles.

AVAH — Frequently Asked Questions

Quick answers to the most common questions about buying AVAH stock.

How much cash does Aveanna Healthcare Holdings Inc. (AVAH) generate from operations?

Aveanna Healthcare Holdings Inc. (AVAH) generated $122.2M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Aveanna Healthcare Holdings Inc.'s free cash flow?

Aveanna Healthcare Holdings Inc. (AVAH) generated $114.8M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Aveanna Healthcare Holdings Inc.'s capital expenditure (CapEx)?

Aveanna Healthcare Holdings Inc. (AVAH) spent $7.4M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.